Academic literature on the topic 'Autonomic cardiovascular modulation'

Air pollutants pose a serious worldwide health hazard, causing respiratory and cardiovascular morbidity and mortality. Pollutants perturb the autonomic nervous system, whose function is critical to cardiopulmonary homeostasis. Recent studies suggest that pollutants can stimulate defensive sensory nerves within the cardiopulmonary system, thus providing a possible mechanism for pollutant-induced autonomic dysfunction. A better understanding of the mechanisms involved would likely improve the management and treatment of pollution-related disease.

Alterations in resting autonomic tone can be pathogenic in many cardiovascular disease states, such as heart failure and hypertension. Indeed, autonomic modulation by way of beta-blockade is a standard treatment of these conditions. There is a significant interest in developing non-pharmacological methods of autonomic modulation as well. For instance, clinical trials of vagal stimulation and spinal cord stimulation in the treatment of heart failure are currently underway, and renal denervation has been studied recently in the treatment of resistant hypertension. Notably, autonomic stimulation is also a potent modulator of cardiac electrophysiology. Manipulating the autonomic nervous system in studies designed to treat heart failure and hypertension have revealed that autonomic modulation may have a role in the treatment of common atrial and ventricular arrhythmias as well. Experimental data on vagal nerve and spinal cord stimulation suggest that each technique may reduce ventricular arrhythmias. Similarly, renal denervation may play a role in the treatment of atrial fibrillation, as well as in controlling refractory ventricular arrhythmias. In this review, we present the current experimental and clinical data on the effect of these therapeutic modalities on cardiac electrophysiology and their potential role in arrhythmia management.

AbstractWe aimed to analyze the effect of an exercise training program in autonomic modulation, and exercise tolerance of hemodialysis and kidney-transplanted patients. 4 groups of exercised and non-exercised patients undergoing hemodialysis and kidney-transplanted subjects had their biochemical tests, and heart rate variability evaluations analyzed. Also, sleep quality, anxiety and depression questionnaires were evaluated. Both exercised groups showed improvements in cardiovascular autonomic modulation, biochemical markers, and exercise tolerance after the exercise training program. The exercised kidney-transplanted patients group showed better improvements in cardiovascular autonomic modulation, biochemical markers, and exercise tolerance when compared to the exercised hemodialysis patients group. Both groups showed improvements in sleep quality, anxiety, and depression. The group of kidney-transplanted patients show better results in the cardiovascular autonomic modulation than subjects undergoing hemodialysis. However, the patients undergoing hemodialysis showed improvements in blood pressure, HDL, hemoglobin and phosphorus, changes not observed in the kidney-transplanted group. Exercise is beneficial for both hemodialysis and kidney-transplanted patients groups. However, exercise programs should be focused mainly in improving cardiovascular risk factors in the HD patients.

Angiotensin-(1-7) counterbalances angiotensin II cardiovascular effects. However, it has yet to be determined how cardiovascular autonomic modulation may be affected by chronic and acute elevation of Ang-(1-7). Hemodynamics and cardiovascular autonomic profile were evaluated in male Sprague-Dawley (SD) rats and transgenic rats (TGR) overexpressing Ang-(1-7) [TGR(A1-7)3292]. Blood pressure (BP) was directly measured while cardiovascular autonomic modulation was evaluated by spectral analysis. TGR received A-779 or vehicle and SD rats received Ang-(1-7) or vehicle and were monitored for 5 h after i.v. administration. In another set of experiments with TGR, A-779 was infused for 7 days using osmotic mini pumps. Although at baseline no differences were observed, acute administration of A-779 in TGR produced a marked long-lasting increase in BP accompanied by increased BP variability (BPV) and sympathetic modulation to the vessels. Likewise, chronic administration of A-779 with osmotic mini pumps in TGR increased heart rate, sympathovagal balance, BPV, and sympathetic modulation to the vessels. Administration of Ang-(1-7) to SD rats increased heart rate variability values in 88% accompanied by 8% of vagal modulation increase and 18% of mean BP reduction. These results show that both acute and chronic alteration in the Ang-(1-7)-Mas receptor axis may lead to important changes in the autonomic control of circulation, impacting either sympathetic and (or) parasympathetic systems.

Acute stroke has been associated with several manifestations of autonomic dysfunction including cardiovascular, sudomotor, thermoregulatory, gastrointestinal and urogenital symptoms. In particular, cardiovascular autonomic impairment including blunted baroreflex has been repeatedly shown to be of prognostic importance in acute stroke. Pathophysiological mechanisms of baroreflex changes in acute stroke include lesions of the central autonomic processing with consequent sympathetic system overactivation and impairment of baroreflex functioning. Previous studies have shown that patients with shifted autonomic balance are more prone to develop cardiac complications and have increased cardiovascular morbidity and mortality. Moreover, autonomic dysregulation may play an important role in secondary brain injury after stroke. Therefore, modifying autonomic functions may have important therapeutic implications in acute stroke. In this article, the role of baroreflex impairment in acute stroke and its possible therapeutic relevance is discussed.

Cardiovascular disease is the leading cause of mortality in the developed world with up to fifty percent of cases being due to sudden cardiac death. Changes in sympatho-vagal balance underpin many cardiovascular conditions including heart failure and myocardial infarction. Neuraxial modulation of the autonomic nervous system is an emerging therapy to prevent ventricular arrhythmias, the main cause of sudden cardiac death. Chapter One reviews our current understanding of how the cardiac autonomic nervous system influences ventricular arrhythmogenesis. A particular focus was on the controversial role of cholinergic receptors and nitric oxide (NO) in parasympathetic protection from ventricular arrhythmias. Tetrahydrobiopterin (BH₄), a critical cofactor for both tyrosine hydroxylase and NO synthases, and the co-transmitter neuropeptide-Y (NPY) may also influence sympathetic triggering of ventricular arrhythmias. This leads to the specific aims of the thesis which were to determine the mechanisms of the cholinergic antifibrillatory effect, investigate the role of cotransmission in arrhythmogenesis and, the mechanistic role of BH4 in autonomic cardiovascular control. Chapter Two detailed the experimental approach taken to investigate the hypotheses. A novel Langendorff heart preparation was developed with intact autonomic nerves to investigate how the stable analogue of acetylcholine, carbamylcholine (CCh) raises ventricular fibrillation threshold (VFT) and whether exogenous or endogenously released NPY lowers VFT. These actions are further investigated using optical mapping, dye free imaging of ventricular cell monolayers, immunohistochemistry, ELISA assays and measurements of NO metabolite production. To investigate the role of BH4 in the sympathetic control of the heart, an IRES-cre recombinase strategy was used to produce genomic deletion of GCH1 (the gene encoding BH4) in sympathetic neurons. Biopterins and plasma catecholamines were measured using HPLC, and blood pressure and heart rate via tail cuff plethysmography. Chapter 3 showed that CCh increased VFT, prolonged action potential duration and flattened the electrical restitution curve. This effect required stimulation of both muscarinic and nicotinic receptors and the generation of nNOS derived NO utilising a cGMP dependent pathway. These observations are in keeping with established evidence demonstrating the obligatory role of the muscarinic receptor and indicate that the role of NO is likely to be via modulation of cholinergic neurotransmission. Chapter 4 studied the role of the sympathetic co-transmitter NPY. NPY has been shown to increase ventricular myocyte calcium dynamics. Plasma levels are also increased post myocardial infarction and during heart failure, and correlate with outcomes. Perfusion of NPY decreased VFT via a Y1 receptor dependent mechanism and increased arrhythmic activity in myocyte monolayers. Direct sympathetic stimulation resulted in NPY release and remained pro-arrhythmic despite β-blockade, an effect that could be abolished by combined β-Y₁ receptor blockade. These observations indicated that NPY may be a novel, pro-arrhythmic trigger amenable to therapeutic pharmacological modulation. Chapter 5 details the generation and phenotyping of two tissue specific Gch1 knockout mouse models. Whilst one model failed to produce significant lowering of BH₄ in sympatho-adrenal tissue, the other did result in a marked neuro-motor phenotype. A biochemical rescue or alternative genomic modification approach would be required to study the cardiovascular phenotype of sympathetic Gch1 deletion in more detail. Chapter 6 is a concluding discussion summarising the main findings of the thesis, placing them in a clinical context and discussing avenues for further research.

Brugada syndrome (BS) is a genetic arrhythmogenic disease characterized by a distinctive electrocardiographic pattern, associated with a high risk for sudden cardiac death (SCD) due to ventricular fibrillation (VF) in absence of structural cardiopathies. Its complex and multifactorial nature turns risk stratification into a major challenge. Although variations in autonomic modulation are commonly related to arrhythmic events in this population, novel markers with higher predictive values are still needed so as to identify those patients at high risk. The autonomic function can be better characterized through the application of standardized maneuvers stimulating the autonomic nervous system (ANS), such as exercise testing or the head-up tilt (HUT) test. Therefore, in this PhD thesis a thorough evaluation of the cardiovascular response to ANS modulations overnight is proposed, as well as in response to exercise and HUT testing, on a clinical database composed of BS patients with different levels of risk (symptomatic and asymptomatic subjects). In this context, the autonomic function was assessed by three main approaches. First, through the characterization and comparison of previously described methods capturing heart rate complexity, baroreflex sensitivity, and non-stationary heart rate variability, never before studied in the context of BS patients; in order to identify new markers capable of distinguishing between symptomatic and asymptomatic patients. According to the results, a lower variability and complexity overnight, as well as a higher vagal tone and a lower sympathetic activity both during exercise and HUT testing, was observed in the symptomatic group. In a second analysis, in order to address the multifactorial nature of the disease, a multivariate approach based on a step-based machine learning method was introduced. By employing features extracted at signal-processing analysis, robust classifiers capable of identifying patients at high risk were proposed. The classifier based on autonomic features extracted during nighttime analysis presented the best performance (AUC=95%), improving previously reported predictive models of risk in BS based on non-invasive parameters. Finally, the third part of this work was focused on the implementation of novel mathematical models and the associated model analysis methods, so as to study the autonomic mechanisms regulating the mechanical and circulatory functions of the cardiovascular system in this population. First, by the integration and evaluation of a computational model capturing the cardiovascular system's dynamics and its autonomic regulation in response to HUT testing. Likewise, a second model-based approach based on a recursive identification of the sympathetic and parasympathetic contributions to ANS regulation was proposed in order to estimate the time-varying autonomic response to exertion and subsequent recovery. The results showed a reduced contractility function, as well as a significantly greater parasympathetic activity during exercise, in symptomatic patients. Finally, in order to combine characteristics extracted from model-based approaches, a prospective study introduced a multivariate classifier based on estimated model parameters. Overall, the obtained results indicate important trends of clinical relevance that provide new insights into the underlying autonomic mechanisms regulating the cardiovascular system in BS, improving physiopathology and prognosis interpretation, with a potential future impact on therapeutic strategies. The proposed approach is presented as a potential instrument for the identification of those asymptomatic patients at high risk who may benefit from a cardioverter defibrillator implantation.
El síndrome de Brugada (SB) es una enfermedad genética asociada a un patrón electrocardiográfico característico y a un elevado riesgo de muerte súbita cardíaca (MSC), causada por fibrilación ventricular (FV) en ausencia de cardiopatías estructurales. Debido a su naturaleza compleja y multifactorial, la estratificación del riesgo supone, en la actualidad, uno de los aspectos más controvertidos. Ciertas alteraciones en la modulación del sistema nervioso autónomo (SNA) se han relacionado con eventos arrítmicos en esta población; no obstante, nuevos marcadores con valores predictivos más elevados que permitan identificar a aquellos pacientes con un alto riesgo de sufrir MSC son todavía necesarios. El uso de maniobras estandarizadas con el objetivo de estimular el SNA permiten mejorar la caracterización de la función autonómica. Por ello, en esta tesis doctoral se propone una evaluación exhaustiva de la respuesta cardiovascular a la modulación del SNA durante la noche, así como en respuesta al ejercicio y a la prueba de mesa inclinada, en una base de datos clínicos compuesta por sujetos con diferentes niveles de riesgo (pacientes sintomáticos y asintomáticos). En este contexto, la evaluación de la función autonómica se llevó a cabo mediante tres estrategias principales. En primer lugar, se caracterizaron y compararon la variabilidad y complejidad del ritmo cardíaco, así como la sensibilidad barorrefleja, en pacientes sintomáticos y asintomáticos, con el objetivo de identificar nuevos marcadores capaces de distinguir entre grupos de pacientes. Los resultados mostraron, en el grupo sintomático, una menor variabilidad y complejidad durante la noche, así como un mayor tono vagal y una menor actividad simpática tanto durante el ejercicio como en respuesta a la prueba de mesa inclinada. En un segundo análisis, se abordó la etiología multifactorial del síndrome mediante un enfoque multivariado basado en un método de aprendizaje automático por etapas. A partir de marcadores extraídos en la etapa anterior, se propusieron modelos predictivos capaces de clasificar pacientes diagnosticados con SB en función de su nivel de riesgo. El mejor clasificador (AUC = 95%) fue diseñado a partir de marcadores autonómicos obtenidos durante la noche, superando modelos predictivos previamente descritos para la estratificación del riesgo en el SB a partir de la combinación de parámetros no invasivos. Finalmente, se analizaron las interacciones entre las funciones mecánica, circulatoria y autonómica de estos pacientes a partir de modelos fisiológicos. En primer lugar, mediante la implementación y evaluación de un modelo computacional integrando la dinámica del sistema cardiovascular y su respuesta autonómica a la prueba de mesa inclinada. Asimismo, se propuso la identificación recursiva de un modelo implementado para el análisis de la evolución temporal de las contribuciones simpática y parasimpática del SNA durante una prueba de esfuerzo. Los resultados mostraron una menor contractilidad, así como una actividad parasimpática significativamente mayor durante el ejercicio, en pacientes sintomáticos. Con el objetivo de combinar características extraídas del modelado fisiológico, un último estudio prospectivo propuso el diseño de un clasificador multivariado integrando los parámetros estimados en esta última etapa. Los resultados obtenidos indican importantes tendencias de relevancia clínica que aportan nuevos conocimientos sobre los mecanismos autonómicos encargados de regular el sistema cardiovascular en el SB. Su interpretación permite mejorar la estratificación del riesgo en estos pacientes y, por tanto, optimizar las estrategias terapéuticas aplicadas. La metodología propuesta se presenta como un instrumento para la identificación de aquellos pacientes con alto riesgo de MSC que podrían beneficiarse de la implantación de desfibriladores automáticos.
Le syndrome de Brugada (BS) est une maladie cardiaque caractérisée par la survenue d’une syncope ou mort subite, provoquées par une arythmie cardiaque, chez les patients avec un coeur structurellement normal, mais présentant des altérations électrocardiographiques spécifiques. Cependant, ces modifications sont intermittentes et varient avec la température ou les traitements appliqués, ce qui rend particulièrement difficile le diagnostic chez un patient donné. En outre, elles sont fortement modulées par le système nerveux autonome (SNA), partie du système nerveux périphérique responsable de la régulation des organes internes. Les défibrillateurs implantables (DI) sont le traitement principal pour les patients symptomatiques, c’est-à-dire les patients documentés d’arythmie ventriculaire, syncope ou ayant survécu à un épisode de mort subite. Cependant, la décision d’implanter un DI peut être très difficile pour des patients asymptomatiques sans antécédents familiaux de morte subite. Dans ce contexte, l’objectif de la thèse était d’améliorer la compréhension de l’influence du SNA chez les patients souffrant du BS. Une méthodologie globale fusionnant traitement du signal, machine learning et modélisation a été proposée durant la thèse. Cette chaine de traitement originale a pu être mise en oeuvre sur trois bases de données de patients BS symptomatiques et asymptomatiques. Les bases de données cliniques utilisées dans ce travail sont le résultat d’une étude prospective, multicentrique dont l’objectif était de provoquer des modifications de l’activité du SNA chez les patients BS. L’acquisition des données s’est déroulée entre 2009 et 2013 dans le service de cardiologie du CHU de Rennes et les participants provenaient de 8 hôpitaux français situés à La Rochelle, Angers, Bordeaux, Brest, Nantes, Rennes, Poitiers et Tours. Afin de caractériser les patients présentant différents niveaux de risque, les participants ont été classés en patients symptomatiques et asymptomatiques, selon leurs historiques cliniques. Les patients symptomatiques devaient présenter les symptômes documentés suivants : arrêt cardiaque dû à une fibrillation ventriculaire, syncopes, vertiges, palpitations et convulsions nocturnes. La base de données est constituée des ECG (12 dérivations) de 87 patients, collectés pendant 24 heures, incluant un test d’orthostatisme (tilt-test) et une épreuve d’effort. L’acquisition était réalisée à l’aide d’un moniteur Holter (ELA medical, Sorin Group, Le Plessis Robinsson, France) à une fréquence d’échantillonnage de 1000 Hz. Par ailleurs, des tilt-tests ont été réalisés sur 32 patients en mesurant de manière non-invasive la pression artérielle et l’ECG avec le moniteur Task Force (CN Systems, Graz, Autriche) à une fréquence d’échantillonnage de 100 Hz et 1000 Hz, respectivement. Des signaux ECG à 12 dérivations échantillonnés à 1000 Hz ont été acquis chez 36 autres patients BS lors d’un test d’exercice avec le moniteur ECG (Cardionics, Webster, Texas). Par conséquent, l’analyse de l’activité du système nerveux autonome est basée sur 3 périodes différentes : 1) une épreuve d’effort, 2) un test d’orthostatisme (tilt-test) et 3) un recueil de données pendant la nuit. La réponse du système nerveux autonome, à ces trois tests, a tout d’abord été évaluée avec des méthodes d’estimation du gain du baroréflexe, de variabilité et de complexité cardiaque. L’une des difficultés du traitement des signaux associés à l’épreuve d’effort et au test d’orthostatisme réside dans leurs natures non-stationnaires. L’analyse spectrale de ces signaux nécessite la mise en oeuvre d’outils spécifiques permettant de décrire une évolution temporelle des caractéristiques fréquentielles. Des analyses temps-fréquence, basées sur la transformée de Wigner-Ville, ont ainsi été utilisées afin d’étudier conjointement, le contenu spectral des signaux, et leurs évolutions temporelles. Cependant, ces méthodes classiques d’analyse de la variabilité cardiaque ne permettent pas de capturer la non-linéarité de la dynamique cardiovasculaire. Ainsi, des méthodes spécifiques d’analyse de la complexité des séries cardiaques ont pu être utilisées. La sensibilité du baroréflexe de ces patients a été évaluée à partir de différentes méthodes proposées dans la littérature. Une série d’indices a ainsi été déduite des signaux avant d’être analysée pour trouver des différences significatives entre les patients symptomatiques et asymptomatiques. Les résultats ont mis en évidence que les indices calculés chez les patients symptomatiques sont associés à une baisse de la variabilité et de la complexité cardiaque pendant la nuit. Par ailleurs, pendant le test d’exercice, les patients symptomatiques ont montré une activité vagale augmentée et un tonus sympathique réduit. Lors de la réponse au tilt-test, les patients symptomatiques ont présenté une augmentation du tonus parasympathique et une réduction de l’équilibre sympatho-vagal par rapport aux patients asymptomatiques. L’étiologie multifactorielle du BS nécessite l’utilisation d’approches complexes capables de capturer les multiples mécanismes sous-jacents à la maladie. Ainsi, une analyse multivariée a été réalisée à partir de la série d’indices calculés précédemment. L’approche globale, basée sur des méthodes de machine learning, permet de combiner de manière optimale les indices autonomiques extraits précédemment, afin de concevoir des classificateurs capables de différencier les patients BS, en fonction de leur symptomatologie. La sélection de ces indicateurs autonomiques, permettant une meilleure caractérisation du BS, peut être difficile surtout lorsque le nombre de sources dépasse la quantité d’observations et que les variabilités entre patients sont significatives. Ainsi, une approche robuste basée sur un processus de sélection de paramètres en deux étapes a été mise en oeuvre. La méthodologie proposée a été optimisée, évaluée et comparée sur les données extraites lors de différents tests autonomiques. Les résultats montrent que le meilleur classificateur (AUC = 95%) a été conçu à partir de marqueurs autonomiques obtenus pendant la nuit, améliorant des modèles prédictifs décrits précédemment pour la stratification du risque dans le BS à partir de la combinaison de paramètres non invasifs. Bien que l’analyse multivariée proposée montre une amélioration des performances de classification par rapport à la littérature, les méthodes utilisées n’intègrent pas de connaissance physiologique dans le traitement des données. Or le BS étant une pathologie complexe et multifactorielle, l’utilisation de modèles mathématiques de connaissance peut s’avérer pertinente car cela permet l’intégration d’information physiologique dans le traitement des données et l’analyse de mécanismes sous-jacents qui sont difficiles ou impossibles à observer en clinique avec des méthodes non-invasives, comme le tonus vagal ou sympathique. Une analyse à base de modèle a été proposée durant la thèse afin : 1) d’étudier la réponse autonomique et hémodynamique au test d’orthostatisme chez des sujets sains et des patients BS, 2) de simuler les réponses vagales et sympathiques durant l’épreuve d’effort chez les patients BS symptomatiques et asymptomatiques. Concernant l’étude de la réponse au test d’orthostatisme, un modèle a été proposé de manière à intégrer les représentations : i) de l’activité électrique cardiaque, ii) de la mécanique des ventricules et des oreillettes, iii) des circulations systémique et pulmonaire et iv) du baroréflexe incluant les voies vagale et sympathique. Le modèle complet permet de simuler les réponses hémodynamiques et autonomiques au test d’orthostatisme. Des analyses de sensibilité, basées sur des méthodes globales et de criblage, ont mis en évidence l’importance de certains paramètres du baroréflexe et en lien avec la description des propriétés diastoliques des ventricules. Ces paramètres ont pu être identifiés, à l’aide d’algorithmes évolutionnaires, afin de créer des modèles spécifiques-patients de 8 sujets sains et 12 patients BS. Les résultats ont montré des différences significatives concernant la réponse sympathique au tilt-test entre sujets sains et BS. Par ailleurs, les patients symptomatiques et asymptomatiques sont associés des modifications significatives des paramètres diastoliques ventriculaires. Concernant les simulations de la réponse autonomique durant l’épreuve d’effort, un algorithme d’identification récursif a pu être mis en oeuvre sur un modèle composé des cavités cardiaques, des circulations systémique et pulmonaire, couplées au baroréflexe. L’identification récursive réalisée sur le modèle a permis une estimation des activités vagale et sympathique durant l’effort chez 13 patients BS symptomatiques et 31 asymptomatiques. Les patients symptomatiques ont montré une élévation significative de l’activité vagale, spécialement à la fin de l’échauffement. Les analyses réalisées sur les modèles proposés, concernant le test d’orthostatisme et l’épreuve d’effort, ont permis une exploration de variables physiologiques, difficilement observables. Les résultats obtenus avec les modèles mettent en évidence des modifications de la réponse hémodynamique cardiaque et confirment des modifications de la balance sympatho-vagale entre les patients symptomatiques et asymptomatiques. En résumé, les résultats obtenus mettent en évidence un déséquilibre de la balance sympathovagale entre les patients symptomatiques et asymptomatiques et montrent l’utilité des indices de variabilité cardiaque pour la classification des patients en fonction de la symptomatologie. Les résultats obtenus sont cohérents avec la littérature, rapportant un tonus vagal plus élevé, ainsi qu’une activité sympathique, variabilité et complexité cardiaques plus faibles, chez les patients symptomatiques. Des études précédentes ont rapporté que la plupart des événements cardiaques majeurs se produisent au repos et pendant le sommeil, ainsi que l’apparition des altérations électrocardiographiques caractéristiques du BS augmente avec la stimulation vagale. Les résultats obtenus pendant la nuit, lorsque l’activité parasympathique est prédominante, ont montré des résultats particulièrement pertinents pour la différentiation des populations de patients. De plus, étant donnée qu’il existe une activité parasympathique significativement plus élevée chez les patients symptomatiques pendant les tests d’exercice et d’orthostatisme par rapport aux sujets asymptomatiques, les résultats soulignent le rôle de l’analyse du tonus vagal pour la stratification du risque dans cette population. Enfin, l’analyse basée sur un modèle du système cardiovasculaire a permis de mettre en évidence des différences concernant les propriétés diastoliques cardiaques et la réponse du baroréflexe pendant le test d’orthostatisme. L’ensemble des résultats de la thèse permet une meilleure caractérisation des profils autonomiques des patients atteints du syndrome de Brugada et laisse envisager une amélioration de la sélection des patients pour implantation d’un DI.

Le syndrome de Brugada (BS) est une maladie génétique responsable de troubles du rythme cardiaque. En raison de la nature complexe et multifactorielle de cette pathologie, la stratification du risque peut s’avérer particulièrement difficile et il est nécessaire de pouvoir définir de nouveaux marqueurs avec des valeurs prédictives élevées afin d’identifier les patients à haut risque. Les événements arythmiques dans cette population étant souvent liés à des modifications de fonctionnement du système nerveux autonome (SNA), l’objectif de la thèse est l’évaluation et comparaison de la réponse cardiovasculaire aux modulations du SNA pendant la nuit, ainsi qu'en réponse à des manœuvres normalisées, telles que l'épreuve d'effort ou le test d'orthostatisme, chez une série de patients BS présentant différents niveaux de risque (sujets symptomatiques et asymptomatiques). Une première partie du travail de thèse est dédiée à l’application de méthodes d'analyse de complexité cardiaque, de sensibilité baroréflexe et de variabilité non-stationnaire du rythme cardiaque, jamais étudiées dans le cadre des patients BS. Dans une deuxième partie, afin d'aborder la nature multifactorielle de la maladie, une approche multivariée basée sur une méthode de machine learning est introduite. En employant des marqueurs extraits à l'analyse du traitement du signal précédent, des classificateurs robustes capables de distinguer les patients à différents niveaux de risque sont proposés. Dans la troisième partie de ce travail, deux modèles mathématiques de connaissances ont été proposés et analysés, afin d'étudier les réponses autonomiques et hémodynamiques au test d’orthostatisme et à l’épreuve d’effort. Enfin, une application prospective d’une approche multivariée intégrant les paramètres extraits à l'étape de modélisation est également présentée. L’ensemble des résultats de la thèse permet une meilleure caractérisation des profils autonomiques des patients BS et laisse envisager une amélioration de la sélection des patients pour implantation d'un défibrillateur implantable
Brugada syndrome (BS) is a genetic arrhythmogenic disease characterized by a distinctive electrocardiographic pattern, associated with a high risk for sudden cardiac death. Its complex and multifactorial nature turns risk stratification into a major challenge. Although variations in autonomic modulation are commonly related to arrhythmic events in this population, novel markers with higher predictive values are still needed so as to identify those patients at high risk. Since the autonomic function can be better characterized through the application of standardized maneuvers stimulating the autonomic nervous system (ANS), the main objective of this thesis is to evaluate and compare the cardiovascular response to ANS modulations overnight, as well as in response to exercise and HUT testing, on a series of BS patients with different levels of risk (symptomatic and asymptomatic subjects). In a first part of this work, we apply previously described methods for the analysis of heart rate complexity, baroreflex sensitivity, and non-stationary heart rate variability, never before studied in the context of BS patients. In a second part, in order to address the multifactorial nature of the disease, a multivariate approach based on a step-based machine learning method is introduced. By employing markers extracted at signal-processing analysis, robust classifiers capable of distinguishing patients at different levels of risk are proposed. The third part of this work has been focused on the proposal of novel mathematical models and the associated model analysis methods, so as to study the autonomic and hemodynamic responses to exercise and HUT testing. Finally, a prospective application of a multivariate approach integrating parameters extracted at the model-based stage is also presented. Overall, the obtained results provide new insights into the underlying autonomic mechanisms regulating the cardiovascular system in BS, improving physiopathology and prognosis interpretation. The proposed approach may be used as an instrument for the identification of those asymptomatic patients at high risk who may benefit from a cardioverter defibrillator implantation
El síndrome de Brugada (SB) es una enfermedad genética asociada a un patrón electrocardiográfico característico y a un elevado riesgo de muerte súbita cardíaca (MSC), causada por fibrilación ventricular (FV) en ausencia de cardiopatías estructurales. Debido a su naturaleza compleja y multifactorial, la estratificación del riesgo supone, en la actualidad, uno de los aspectos más controvertidos. Ciertas alteraciones en la modulación del sistema nervioso autónomo (SNA) se han relacionado con eventos arrítmicos en esta población; no obstante, nuevos marcadores con valores predictivos más elevados que permitan identificar a aquellos pacientes con un alto riesgo de sufrir MSC son todavía necesarios. El uso de maniobras estandarizadas con el objetivo de estimular el SNA permite una mejor caracterización de la función autonómica. El principal objetivo de esta tesis doctoral es, por tanto, la evaluación exhaustiva de la respuesta cardiovascular a la modulación del SNA en una serie de pacientes con SB y diferentes niveles de riesgo (sujetos sintomáticos y asintomáticos), a través de diferentes maniobras autonómicas, con la finalidad de identificar nuevos marcadores potencialmente útiles para la estratificación de riesgo en esta población. En este contexto, la evaluación de la función autonómica se llevó a cabo mediante tres estrategias principales. En primer lugar, se caracterizaron y compararon la variabilidad y complejidad del ritmo cardíaco, así como la sensibilidad barorrefleja, en pacientes sintomáticos y asintomáticos, con el objetivo de identificar nuevos marcadores capaces de distinguir entre grupos de pacientes. Los resultados mostraron, en el grupo sintomático, una menor variabilidad y complejidad durante la noche, así como un mayor tono vagal y una menor actividad simpática tanto durante el ejercicio como en respuesta a la prueba de mesa inclinada. En un segundo análisis, se abordó la etiología multifactorial del síndrome mediante un enfoque multivariado basado en un método de aprendizaje automático por etapas. A partir de marcadores extraídos en la etapa anterior, se propusieron modelos predictivos capaces de clasificar pacientes diagnosticados con SB en función de su nivel de riesgo. El mejor clasificador (AUC = 95%) fue diseñado a partir de marcadores autonómicos obtenidos durante la noche, superando modelos predictivos previamente descritos para la estratificación del riesgo en el SB a partir de la combinación de parámetros no invasivos. Finalmente, se analizaron las interacciones entre las funciones mecánica, circulatoria y autonómica de estos pacientes a partir de modelos fisiológicos. En primer lugar, mediante la implementación y evaluación de un modelo computacional integrando la dinámica del sistema cardiovascular y su respuesta autonómica a la prueba de mesa inclinada. Asimismo, se propuso la identificación recursiva de un modelo implementado para el análisis de la evolución temporal de las contribuciones simpática y parasimpática del SNA durante una prueba de esfuerzo. Los resultados mostraron una menor contractilidad, así como una actividad parasimpática significativamente mayor durante el ejercicio, en pacientes sintomáticos. Con el objetivo de combinar características extraídas del modelado fisiológico, un último estudio prospectivo propuso el diseño de un clasificador multivariado integrando los parámetros estimados en esta última etapa. Los resultados obtenidos indican importantes tendencias de relevancia clínica que aportan nuevos conocimientos sobre los mecanismos autonómicos encargados de regular el sistema cardiovascular en el SB. Su interpretación permite mejorar la estratificación del riesgo en estos pacientes y, por tanto, optimizar las estrategias terapéuticas aplicadas. La metodología propuesta se presenta como un instrumento para la identificación de aquellos pacientes con alto riesgo de MSC que podrían beneficiarse de la implantación de desfibriladores automáticos

Submitted by LUIZ HENRIQUE NATALI null (luhnatali@hotmail.com) on 2016-08-30T19:05:39Z No. of bitstreams: 1 DISSERTAÇÃO completa.pdf: 1855365 bytes, checksum: e1aaabe0f34e47039840d7783425d449 (MD5)
Approved for entry into archive by Juliano Benedito Ferreira (julianoferreira@reitoria.unesp.br) on 2016-08-31T16:37:51Z (GMT) No. of bitstreams: 1 natali_lh_me_araca.pdf: 1855365 bytes, checksum: e1aaabe0f34e47039840d7783425d449 (MD5)
Made available in DSpace on 2016-08-31T16:37:51Z (GMT). No. of bitstreams: 1 natali_lh_me_araca.pdf: 1855365 bytes, checksum: e1aaabe0f34e47039840d7783425d449 (MD5) Previous issue date: 2016-08-01
A hipertensão arterial é frequentemente associada à prejudicada sensibilidade do barorreflexo (SBR). Em ratas espontaneamente hipertensas (SHR), a gravidez reduz a pressão sanguínea, e este efeito tem sido associado ao aumento da biodisponibilidade de óxido nítrico (NO). O aumento da biodisponibilidade do NO tem sido associado a uma SBR restaurada em animais hipertensos. Por isso, testamos a hipótese de que a gravidez melhora a SBR em SHR. Foram realizados experimentos em ratas Wistar e SHR não prenhas (NP) e prenhas (P), sendo dez virgens e dez prenhas em cada grupo, para avaliar a modulação autonômica cardíaca e vasomotora, a SBR em condições basais (espontânea) e após a administração de doses de fenilefrina (FE) e nitroprussiato de sódio (NPS). Séries temporais com valores de intervalo de pulso (IP) e de pressão arterial sistólica (PAS) foram geradas e tiveram espectros calculados pela Transformada Rápida de Fourrier. Em seguida, os espectros foram integrados em bandas de baixa (LF) e alta freqüência (HF), e os poderes das bandas foram tomadas como índices de modulação autonômica cardiovascular. Observamos reduzida pressão arterial média em ratas Wistar prenhas (W-P) e SHR prenhas (SHR-P) quando comparado com ratas NP, no entanto, a frequência cardíaca basal não foi alterada. Em SHR-NP, a análise espectral revelou modulação autonômica cardiovascular alterada quando comparado com os outros grupos (banda de alta LF do espectro PAS e banda de alta HF dos espectros IP). No entanto, em SHR-P os parâmetros autonômicos foram encontrados semelhantes aos observados em ratas Wistar-NP, sugerindo que a prenhez restaurou as alterações na modulação autonômica. A SBR espontânea não foi alterada em SHR-P quando comparado com W-P. A prenhez reduziu a SBR durante situações de hipotensão no grupo Wistar. A SBR avaliada após a administração de FE ou NPS foi menor em SHR-NP em comparação com Wistar-NP, e não se alterou pela prenhez. Em conclusão, a gravidez não melhorou as SBR em SHR, mas normalizou a alterada modulação vasomotora simpática e a modulação parassimpática cardíaca observados em SHR-NP.
Hypertension is frequently associated to impaired baroreflex sensitivity (BRS). In spontaneously hypertensive rats (SHR), pregnancy reduces blood pressure, and this effect has been associated to increased nitric oxide (NO) availability. Increased NO bioavailability has been linked to improved BRS in hypertensive animals. Therefore, we tested the hypothesis that pregnancy improves the BRS in SHR. Experiments were performed to evaluate the vasomotor and cardiac autonomic modulation, and the BRS at baseline conditions (spontaneous) and after phenylephrine (PE) and sodium nitroprusside (SNP) administrations in female non-pregnant (NP) and pregnant (P) Wistar rats and SHR. Time series with pulse interval (PI) and systolic arterial pressure (SAP) values were generated and had spectra calculated by Fast Fourier Transform. Next, spectra were integrated into low (LF) and high frequency (HF) bands, and the powers of the bands were taken as indexes of cardiovascular autonomic modulation. Reduced mean arterial pressure was observed in Wistar pregnant (W-P) and SHR pregnant (SHR-P) when compared to NP matched rats, however the heart rate was not altered. In SHR-NP, spectral analysis revealed altered cardiovascular autonomic modulation when compared to the other groups (high LF band of the SAP spectra and high HF band of the PI spectra). However, in SHR-P the autonomic parameters were found similar to those observed in Wistar-NP, suggesting that pregnancy prevented changes in autonomic modulation. Spontaneous BRS was not altered in SHR-P when compared to W-P. Pregnancy reduced the BRS during hypotension in Wistar group. BRS assessed with PE and SNP administration was found lower in SHR-NP as compared to Wistar-NP, and it was not altered by pregnancy. In conclusion, pregnancy did not improve the BRS in SHR but normalized altered sympathetic vasomotor modulation and parasympathetic cardiac modulation in SHR.

Hemodynamic effects of insulin resistance (IR) are thought to be largely dependent on its relationship with body mass index (BMI) and blood pressure (BP) levels. The first part of the present thesis was aimed at exploring whether IR is associated with hemodynamic indices of cardiovascular function in a large sample of non-diabetic individuals from the general population (n=731) and if so, to explore if such relationship is continuous across different categories of BMI (lean, overweight and obese), and BP (normal BP, high-normal BP and hypertension). IR was assessed with the homeostasis model assessment of IR (HOMA-IR). Based on a value of HOMA-IR of 2.09 (75th percentile of distribution curve), subjects were classified as insulin-sensitive (IS, HOMA<2.09) or insulin-resistant (IR, HOMA≥2.09). Synchronized beat-to-beat recordings of stroke volume (impedance cardiography) and R-R interval (ECG), along with repeated BP measurements were performed over 5 minutes. Stroke index (SI), cardiac index (CI), systemic vascular resistance index (SVRI), left cardiac work index (LCWI), pre-ejection period (PEP) and left ventricular ejection time (LVET) were computed and averaged. In analysis of co-variance allowing for confounders, IR subjects showed significantly higher BP levels and SVRI, and reduced R-R interval, SI, CI, LCWI, PEP and LVET. These differences remained significant when analyses were performed within each BMI and BP category. Overall, these results indicate that effects of IR on hemodynamic indices of cardiovascular function are continuous across different BMI and BP categories, reinforcing the importance of IR in the pathogenesis of cardiovascular alterations beyond its association with obesity and hypertension. The finding of a significant association between IR and hemodynamic alterations even in lean and normotensive subjects was the rationale to explore potential mechanisms for these alterations in this selected group of subjects. Specific objectives of this second part of the thesis were: 1) To explore the relationship between insulin resistance and systemic hemodynamics, cardiac baroreflex sensitivity and indices of autonomic CV modulation. 2) To explore the relationship of insulin resistance with 24h heart rate, average blood pressure levels and blood pressure variability over the 24h; and 3) To explore the relationship of insulin resistance with central blood pressure levels and with measures of large artery stiffness and wave reflections. The study population for these analyses was constituted by subjects who were below the 30th percentile of diastolic blood pressure (DBP) distribution curve (DBP ≤72 mmHg) and who had no elevation in systolic BP levels. In addition, subjects were excluded in case of diabetes mellitus (fasting blood glucose ≥126 mg/dL or use of medications for previously diagnosed type 2 diabetes) obesity (BMI≥30) or taking medications with effects on BP. A total of 90 subjects fulfilling inclusion criteria were considered for the present analysis and underwent further assessments. Insulin resistance was assessed with HOMA-index and subjects classified into IR tertiles, based on the distribution of HOMA-index values. 24h Ambulatory BP monitoring was performed. Mean SBP and DBP were averaged for the day, night and 24h, and the respective day-to-night dipping was calculated. BPV was assessed for SBP and DBP as 24h standard deviation (SD), weighted 24h SD (wSD), daytime and night-time SD. Recordings of pulse waveform were obtained by means of a previously validated oscillometric device for ambulatory BP monitoring with in-built transfer-function like method. Aortic pulse wave velocity (PWV, m/s) and other measures derived from pulse wave analysis such as augmentation index (AIx, %), central SBP (cSBP), central DBP (cDBP) and central pulse pressure (cPP) were computed. Peripheral SBP and DBP, and heart rate (HR) were recorded and pulse pressure (PP) calculated as the difference between SBP and DBP. Non-invasive assessment of beat-to-beat BP, R-R interval (ECG) and stroke volume (by means of impedance cardiography) were performed during 10 min in supine position and specific hemodynamic indices associated with their measurement were computed and averaged: RRI (msec), heart rate (HR, bpm), stroke volume index (SI, mL/beat/m2), cardiac index (CI, L/min/m2), SBP (mmHg) and DBP (mmHg), systemic vascular resistance index (SVRI, dyn/sec/cm-5/m2), left cardiac work index (LCWI, Kg/m/m2), pre-ejection period (PEP, msec), left ventricular ejection time (LVET, msec) and PEP/LVET ratio were calculated. Cardiac autonomic modulation was assessed by computer analysis of 10 min beat-to-beat BP and ECG recordings in resting supine position. Cardiac baroreflex sensitivity (BRS) was estimated by sequence method. Total variance, low-frequency (LF) and high-frequency (HF) spectral components of HR variability (HRV) were assessed by autoregressive analysis. LF/HF ratio was calculated. After multiple regression analysis, adjusting for common confounders such as age, sex, HR and BMI, increasing values of HOMA-IR were associated with reduced RRI, SI, CI, and with increased SVRI, SBP and DBP. IR was also associated with reduced BRS (up, down, and total slopes), decreased parasympathetic indices of autonomic CV modulation (SDRRI, HF-power, total power) and a predominance of sympathetic component of HRV (increased LF/HF ratio). Increasing values of HOMA-IR were also associated with increased HR and average SBP levels (during day, night and 24-h period), with augmented BP variability (Day SBP SD, and SBP wSD) and with a reduced dipping of HR. Finally, insulin resistance was shown to be associated with increasing values of aortic PWV, and with higher central and peripheral SBP and DBP levels. Overall, these results support significant associations between insulin resistance and changes in hemodynamic and autonomic indices of cardiovascular function, even after accounting for common confounders. These findings suggest that in normotensive healthy adults, increases in insulin resistance may promote alterations in autonomic cardiovascular modulation, in systemic hemodynamics and in arterial stiffness, all of which are known contributors to the pathogenesis of hypertension.

A síncope neurocardiogênica (SINC) é causada por redução global e aguda do fluxo sanguíneo cerebral, subsequente à hipotensão arterial, com perda transitória da consciência e do tônus postural. Entretanto, existem divergências, quanto às repostas das variáveis cardiovasculares que antecedem o início da SINC, provocada pelo seu principal teste diagnóstico, a manobra postural passiva (MPP) ou Tilt-test. Recentemente, a possibilidade de analisar as variáveis cardiovasculares, com métodos computacionais não-invasivos, lineares (ML) e não lineares (MNL) tem permitido o estudo das entropias, da variabilidade da frequência cardíaca (VFC), da pressão arterial sistólica (VPAS) e da sensibilidade barorreflexa (SBR); estudos preliminares sugerem que a SINC poderia estar relacionada ao desequilíbrio da modulação autonômica dessas variáveis. Objetivo: usar métodos computacionais, ML e MNL, na análise da VFC, e ML na análise da VPAS e da SBR, em pacientes com história clínica de SINC, com resposta positiva ou negativa à MPP, e em indivíduos saudáveis. Métodos: Foram estudados 51 indivíduos, divididos em 3 grupos, sendo 16 positivos, 18 negativos e 17 saudáveis. Os ML usam algoritmos nos domínios do tempo (DT) e da frequência (DF) (Transformada rápida de Fourier), e os MNL usam alogarítmos da entropia amostral (SampEn) m=2 e r= 20%. Foram analisados 2 momentos: Pré-Tilt (posição supina; trechos com 1000-1500 pontos) e Tilt pré-síncope (70º de inclinação; trechos com 1000-1500 pontos; anteriores à síncope), sendo estudados os mesmos momentos para o grupo controle. Resultados: Não foram encontradas diferenças estatísticas entre os grupos TTP, TTN e Controle para os parâmetros: Idade (anos), Peso (kg), Altura (m) e IMC (kg/m2), pressão arterial sistólica (PAS), pressão arterial diastólica (PAD), frequência cardíaca (FC) e frequência respiratória. Na análise VFC por meio de ML no DT e DF, no momento Pré-Tilt e Tilt pré-síncope, não foi encontrada diferenças estatísticas 8 entre os grupos TTP, TTN e Controle para os parâmetros Mean-iRR(ms), SDiRR(ms), RMSSD(ms), LF(un) (ms2), HF(un) (ms2) e LF/HF. Comparando-se os momentos Pré-Tilt vs Tilt nos grupos TTP, TTN e Controle (análise intra-grupo) observamos diferenças significantes para as variáveis: Mean-iRR(ms), SD-iRR(ms), RMSSD(ms), LF(un), HF(un) (ms2) e LF/HF. Houve na análise da VFC por MNL (SampEn) no grupo Controle, redução significativa dos valores entre as fases Pré-Tilt vs Tilt (2,19 ± 0,40 vs 1,68 ± 0,50, p = 0,001). Houve em ambos os grupos (TTP, TTN e Controle) aumento significativo do LF-PAS, quando comparamos as fases Pré-Tilt vs Tilt (TTP: 6,72 ± 5,67 vs 13,03 ± 10,759 mmHg2, p = 0,001; TTN: 7,25 ± 4,22 vs 13,42 ± 8,62 mmHg2, p = 0,013; Controle: 5,99 ± 2,20 vs 23,07 ± 6,26 mmHg2, p < 0,0001). Além disso, evidenciaram-se maiores valores, estatisticamente significantes, quando comparamos os grupos Controle vs TTP no momento Tilt (23,07 ± 6,26 vs 13,03 ± 10,59 mmHg2, p < 0,001) e Controle vs TTN no momento Tilt (23,07 ± 6,26 vs 13,42 ± 8,62 mmHg2, p < 0,001). Houve em todos os grupos redução significativa da SBR, quando comparamos as fases Pré-Tilt vs Tilt (TTP: 30,22 ± 15,67 vs 13,16 ± 6,08 ms/mmHg, p < 0,0001; TTN: 22,98 ± 11,23 vs 11,55 ± 3,34 ms/mmHg, p < 0,0001; e Controle: 26,75 ± 6,94 vs 12,25 ± 3,88 ms/mmHg, p < 0,0001). Além disso, no grupo TTP e Controle, houve redução significativa dos valores do índice de efetividade barorreflexa (BEI) entre as fases Pré-Tilt vs Tilt (0,50 ± 0,15 vs 0,40 ± 0,13, p = 0,033) e (0,54 ± 0,07 vs 0,46 ± 0,16, p =0, 030) respectivamente. Conclusões: os achados do presente estudo permitiram as seguintes conclusões: 1- a VFC, com métodos lineares (domínios do tempo e frequência) e não lineares (Entropia Amostral), bem como a VPAS (domínios do tempo e da frequência) e a SBR não documentaram nas fases Pré-Tilt e Tilt pré- síncope (fase de estabilidade das variáveis, após a mudança postural até momento anterior ao aparecimento dos pródromos ou da síncope), diferenças estatísticas entre os 2 grupos de pacientes adultos e com história altamente sugestiva de SINC, como doença isolada, com Tilt-test positivo e negativo; 2- o grupo Controle saudável somente foi diferente dos grupos TTP e TTN no parâmetro LF da VPAS; a importância fisiológica desse achado é de difícil explicação, porque não existem na 9 literatura, para esse parâmetro, valores normais da média e dos intervalos de confiança.
Neurocardiogenic syncope (SYN) is caused by a global and acute reduction of cerebral blood flow, subsequent to hypotension, with transient loss of consciousness and postural tone. However, there are differences in the responses of the cardiovascular variables that precede the beginning of the SYN, caused by its main diagnostic test, the passive postural maneuver (PPM) or Tilt-test. Recently, the possibility of analyzing cardiovascular variables using non-invasive, linear (ML) and non-linear (MNL) computational methods has allowed the study of entropies, heart rate variability (HRV), systolic blood pressure variability (VPAS) and baroreflex sensitivity (SBR). Preliminary studies suggest that the SYN could be related to the imbalance of the autonomic modulation of these variables. Objective: To use computer methods, ML and MNL, in the analysis of HRV, and ML in the analysis of VPAS and SBR, in patients with a clinical history of SYN, with positive or negative response to PPM, and in healthy individuals. Methods: Fifty-one individuals were studied, divided into three groups: 16 positive, 18 negative and 17 healthy. MLs use algorithms in the time (DT) and frequency (DF) (Fast Fourier Transform) algorithms, and MNLs use sample entropy m (2) and r = 20%. Two moments were analyzed: Pre-Tilt (supine position, recording 1000-1500 points) and pre-syncope Tilt (70º inclination, recording 1000-1500 points, prior to syncope), being studied the same moments for the control group. Results: There were no statistical differences between the TTP, TTN and Control groups for the parameters: Age (years), Weight (kg), Height (m) and BMI (kg / m2), systolic blood pressure Diastolic (DBP), heart rate (HR) and respiratory rate. No statistical differences were found between the TTP, TTN and Control groups (in the Pre-Tilt and Tilt) for the Mean-iRR (ms), SD-iRR (ms), RMSSD (ms), LF (un) (ms2), HF (un) (ms2) and LF / HF. Comparing the Pre-Tilt vs Tilt moments in the TTP, TTN and Control groups (intra-group analysis) we observed significant differences for the variables: Mean-iRR (ms), SD-iRR (ms), RMSSD (ms), 11 LF (Un), HF (un) (ms2) and LF / HF. There was a significant reduction in the values between the Pre-Tilt vs Tilt phases (2.19 ± 0.40 vs 1.68 ± 0.50, p = 0.001) in the analysis of HRV by MNL (SampEn) in the Control group. There was a significant increase in LF-PAS in both groups (TTP, TTN and Control) when we compared the Pre-Tilt vs Tilt phases (TTP: 6.72 ± 5.67 vs 13.03 ± 10.759 mmHg2, p = 0.001; TTN: 7.25 ± 4.22 vs 13.42 ± 8.62 mmHg2, p = 0.013; Control: 5.99 ± 2.20 vs. 23.07 ± 6.26 mmHg2, p <0.0001). In addition, statistically significant higher values were found when we compared the Control vs TTP groups at the time of Tilt (23.07 ± 6.26 vs 13.03 ± 10.59 mmHg2, p <0.001) and Control vs. TTN at the time of Tilt (23.07 ± 6.26 vs 13.42 ± 8.62 mmHg2, p <0.001). There was a significant reduction of SBR in all groups when comparing the Pre-Tilt vs Tilt phases (TTP: 30.22 ± 15.67 vs. 13.16 ± 6.08 ms / mmHg, p <0.0001; P <0.0001, and control: 26.75 ± 6.94 vs 12.25 ± 3.88 ms / mmHg, p <0, 0001). In addition, in the TTP and Control group, there was a significant reduction in baroreflex effectiveness index (EIB) between the Pre-Tilt vs. Tilt phases (0.50 ± 0.15 vs. 0.40 ± 0.13, p = 0.033) and (0.54 ± 0.07 vs 0.46 ± 0.16, p = 0.030) respectively. Conclusions: The findings of the present study allowed the following conclusions: 1 - HRV, with linear methods (time and frequency domains) and nonlinear (Entropy Amostral), as well as VPAS (time domain and frequency domain) and SBR did not document Pre-Tilt and Tilt phases pre-syncope (Stability of variables, after postural change until the time before prodrome or syncope appeared), statistical differences between the 2 groups of adult patients and with a highly suggestive history of SYN, As isolated disease, with positive and negative Tilt-test; 2- the Healthy control group was only different from the TTP and TTN groups in the LF parameter of the VPAS; The physiological importance of this finding is difficult to explain because there are no normal values of the mean and confidence intervals in the literature for this parameter.

Submitted by Nadir Basilio (nadirsb@uninove.br) on 2018-07-16T20:49:37Z No. of bitstreams: 1 Danielle da Silva Dias.pdf: 3090914 bytes, checksum: d346273638612b707bd90d03e883db70 (MD5)
Made available in DSpace on 2018-07-16T20:49:37Z (GMT). No. of bitstreams: 1 Danielle da Silva Dias.pdf: 3090914 bytes, checksum: d346273638612b707bd90d03e883db70 (MD5) Previous issue date: 2017-10-19
The aim of the present study was to evaluate the impact of combined exercise training on the development of cardiovascular and neuroimmune dysfunctions induced by fructose overload in sedentary hypertensive (SH), SHR + fructose (HF) and SHR + fructose + training (Treadmill + ladder, 60 days, 40-60% of maximal capacity) (HFTC). The groups were divided into subgroups evaluated at 7, 15, 30 and 60 days (n=6/group/time). Fructose was offered in drinking water (10%). Metabolic, hemodynamic, autonomic, inflammatory, and oxidative stress parameters were evaluated. Regarding the metabolic profile, the HF group showed increase in white adipose tissue in relation to the H group and the HFTC group diminished these values values at 60 days (HF: 1.91± 0.10 vs. H: 1.61±0.11 and HFTC: 1.42±0.13 g). The HF group presented reduction in insulin sensitivity (HF: 3.15±0.2 vs. H: 3.96±0,1 and HFTC: 4.32±0.2 %/min) at 60 days in relation to H and HFTC groups. The HF group increased triglycerides (TG) when compared to H group at 60 days of protocol (HF:139±7 vs. H: 106±5 and HFTC:107±8 mg/dL). TG were lower in the HFTC group than in the HF group at 60 days. Fructose consumption (HF) induced a further increase in mean arterial pressure (MAP) at 30 and 60 days in SHR (HF-30 days: 1534 e HF-60 days: 184±4 vs. H-30 days: 1413 e H-60 days: 1653 mmHg). On the other hand, combined exercise training reduced MAP in 30 and 60 days of fructose overload in relation to the HF group (HFTC: 142±8 and 167±6 mmHg). There was a decrease on heart rate variability (VAR-PI) in 7 days and 60 days in the HF group (10.5±1.3 and 40.81± 6.12 ms2) in relation to the H group (23±1.5 and 59.7 ±3.4 ms2); the HFTC group did not presented this impairment (26.8±2.1 and 70.4±5.9 ms2). In addition, the HF group had a lower alpha index (spontaneous baroreflex) at 7 days compared to the H group (0.23±0.03 vs. 0.35±0.01 ms/mmHg), which was not observed in the HFTC group. There was an increase in IL-6 and TNFα in cardiac tissue at 15, 30 and 60 days in the HF and HFTC groups compared to the H groups. The HFTC group presented higher IL-10 values in the heart at 7 days compared to the HF group (28±1 vs. 16±1 pg/mg of protein). The HF group presented increase in cardiac lipoperoxidation at 30 and 60 days in relation to the H group. The HFTC group decreased lipoperoxidation compared to HF group at 60 days (1302±58 vs. 1956±215 cps/mg protein) and there was also reduction in protein oxidation in this time. In addition, there was an increase in NADPH oxidase in the HF group at 60 days when compared to the H group and reduction in this parameter in the HFTC group in relation to the HF group at the same time (H: 0.18±0.02; HF: 0.46 ±0.04; HFTC 0.35 ±0.03 μm/mg protein). Considering the redox balance, the HFTC group presented increase in this evaluation in 7, 15, 30 and 60 days in relation to H and HF groups. Our results show that only 7 days of fructose consumption impaired the autonomic control of the circulation, followed by reduction in plasma nitrites and increase in cardiac IL-6 and TNF- in 15 days, culminating in increased cardiac protein and lipids damage, which are probably associated with the appearance of cardiometabolic dysfunctions after 30 days of protocol in SHR. In addition, combined exercise training prevented the development of autonomic dysfunction in this model, which probably promoted favorable neuroimmune changes and oxidative stress profile, culminating in a marked attenuation of cardiometabolic dysfunctions in SHR submitted to fructose consumption. Together our findings reinforce the role of the autonomic nervous system in the genesis of cardiometabolic dysfunctions and evidence an important role of combined exercise training in the prevention of these alterations.
O objetivo do presente estudo foi avaliar o impacto do treinamento físico combinado no desenvolvimento das disfunções cardiovasculares e neuroimunes induzidas pela sobrecarga de frutose em ratos hipertensos (SHR). Para isto SHR foram divididos em grupos: SHR (H), SHR+frutose (HF) e SHR+frutose+treinamento físico combinado (esteira+escada, 60 dias, 40-60% da capacidade máxima) (HFTC). A frutose foi oferecida na água de beber (10%). Parâmetros metabólicos, hemodinâmicos, autonômicos, inflamação e estresse oxidativo foram avaliados em subgrupos (n=6 grupo/tempo) em 7, 15, 30 e 60 dias. Com relação ao perfil metabólico o grupo HF aumentou o peso do tecido adiposo branco em relação ao grupo H e o grupo HFTC reduziu esses valores em 60 dias (HF: 1,91± 0,10 vs. H: 1,61±0,11 e HFTC: 1,42±0,13 g). Houve redução de sensibilidade à insulina no grupo HF em 60 dias (HF: 3,15±0,2 vs. H:3,96±0,1 e HFTC: 4,32±0,2 %/min) em relação aos grupos H e HFTC. O grupo HF apresentou aumento de triglicérides (TG) quando comparado ao grupo H em 60 dias protocolo (HF:139±7 vs. H: 106±5 e HFTC:107±8 mg/dl), o que não foi observado no grupo HFTC. O consumo de frutose (grupos HF) induziu um aumento adicional na pressão arterial média (PAM) em 30 e 60 dias de protocolo nos SHR (HF-30 dias: 1534 e HF-60 dias: 184±4 vs. H-30 dias: 1413 e H-60 dias: 1653 mmHg). Por outro lado, o treinamento físico combinado (HFTC: 142±8 e 167±6 mmHg) reduziu a PAM em 30 e 60 dias de sobrecarga de frutose em relação aos grupos HF. Não foram observadas diferenças na frequência cardíaca basal entre os grupos. Houve diminuição da variabilidade da frequência cardíaca (VAR-IP) em 7 dias e em 60 dias nos grupos HF (10,51,3 e 40,816,12 ms2) em relação aos grupos H (231,5 e 59,73,4 ms2); o grupo HFTC não apresentou esse prejuízo (26,82,1 e 70,45,9 ms2). Além disso, o grupo HF apresentou menor índice alfa (barorreflexo espontâneo) em 7 dias em relação ao grupo H (0,230,03vs. 0,350,01 ms/mmHg), o que não foi observado no grupo HFTC. Houve aumento de IL-6 e TNFα no coração em 15, 30 e 60 dias nos grupos HF e HFTC em relação aos respectivos grupos H. O grupo HFTC apresentou maiores valores de IL-10 cardíaco em 7 dias em relação ao grupo HF (281 vs. 161 pg/mg de proteína). Os grupos HF apresentaram aumento de lipoperoxidação cardíaca em 30 e 60 dias em relação aos grupos H; o grupo HFTC diminuiu a lipoperoxidação em relação ao grupo HF em 60 dias (130258 vs.1956215 cps/mg proteína), além de reduzir a oxidação de proteínas em tecido cardíaco nesse mesmo tempo. Adicionalmente, houve um aumento na NADPH oxidase no grupo HF em 60 dias em relação ao grupo H e redução no grupo HFTC em relação ao grupo HF no mesmo tempo (H: 0,180,02; HF: 0,460,04; HFTC 0,350,03 µm/mg de proteína). No balanço redox, o grupo aos grupos H e HF apresentaram redução da razão GSH/GSSG em 7, 15, 30 e 60 dias em relação aos grupos HFTC. Nossos resultados evidenciam que com apenas 7 de consumo de frutose houve prejuízo no controle autonômico da circulação, que foi seguida por redução de nitritos, aumento de IL-6 e TNF- no coração em 15 dias, culminando em aumento de lesão à proteínas e lipídeos nesse tecido, que provavelmente se associam ao aparecimento das disfunções cardiometabólicas a partir de 30 dias de protocolo nos SHR. Adicionalmente, o treinamento físico combinado impediu o desenvolvimento da disfunção autonômica neste modelo, o que provavelmente promoveu alterações neuroimunes e de perfil de estresse oxidativo favoráveis, culminado em marcante atenuação das disfunções cardiometabólicas em SHR submetidos ao consumo de frutose. Em conjunto nossos achados reforçam o papel do sistema nervoso autônomo na gênese das disfunções cardiometabólicas e evidenciam um importante papel do treinamento físico combinado na prevenção dessas alterações.

Submitted by Nadir Basilio (nadirsb@uninove.br) on 2015-07-20T18:01:54Z No. of bitstreams: 1 Suely Tomimura.pdf: 1781054 bytes, checksum: acaac7dbd088721fbe65530e5cd96c5f (MD5)
Made available in DSpace on 2015-07-20T18:01:54Z (GMT). No. of bitstreams: 1 Suely Tomimura.pdf: 1781054 bytes, checksum: acaac7dbd088721fbe65530e5cd96c5f (MD5) Previous issue date: 2013-12-17
Due to the increasing numbers of Systemic Arterial Hypertension (HBP) patients in population and its senescence, steadily increased from 600 million in 1980 to 1.2 billion in 2008. The World Health Organization (WHO) in 2009 attributed to high blood pressure (BP) was the death cause for 9.5 million people worldwide. Currently, the hypertension has become a serious public health problem. This entity is an important risk factor for congestive heart failure, cerebrovascular disease, acute myocardial infarction, nephropathy, retinopathy and peripheral vascular insufficiency. Studies have suggested that laser photobiomulation, employing a low power, acts into the inflammatory and proliferative phases of tissue repair, by modulating the inflammatory mediators synthesis as same as the Reactive Oxygen Species (ROS). According scientific publications indicate that the inflammation component is closely related to systemic arterial hypertension as well as possibly to the oxidative stress, both participates in the Hypertension genesis. The aim of this study was to verify the long-term effects of Low Level Laser Therapy (LLLT) application in Spontaneously Hypertensive Rats-SHR (Spontaneously Hypertensive Rats) through on cardiovascular autonomic modulation and oxidative stress in the blood. The experiment consisted in 3 phases: Phase I – LLLT irradiation on SHR: The experiment's phase I consisted of animal’s irradiation, when the laser group received three times LLLT applications weekly for a 7 weeks total; the sham group received three times per week of LLLT simulation for 7 weeks and a total of 21 applications. Prospective, randomized, controlled study, with 16 SHR approximately 2 months age, randomly divided into 2 groups : Sham (n = 8) and Laser (n = 8). The animals were irradiated in a prompt, onto the tail’s dorsal area, using a Diode Laser (MMOptics, São Carlos, SP, Brazil) with a wavelength (λ) of 780 ± 2 (nm), output power at 40 mW, with a 0.04 cm2 beam area, dose of 30 J/cm2 power density of 1W/cm2 and irradiation time of 90 s. In Phase II - Hemodynamic and autonomic cardiovascular evaluation: for a period of 7 weeks, consisted in the cannulation procedure, collecting and analysis. The animals were cannulated, evaluated hemodynamically and analyzed the cardiovascular autonomic modulation. Phase III - Oxidative stress analysis, were analyzed: a) protein damage; b) cell membrane damage; c) antioxidant enzyme activity; d) nitrite concentrations. Data from phase II and III were collected and statistically analyzed applying One Way ANOVA test, followed by post hoc Student - Newman Keulls and considering the significance level of p < 0.05, equivalent to an error α 0.05. The results demonstraded hemodynamic parameters of group LLLT treated showed a BP reduction, when compared with the Sham group. In laser group the diastolic arterial pressure (DAP) showed a reduction of -14 mmHg (± 143 * 4 x 157 ± 3 mmHg Sham) and mean arterial pressure (MAP) - 13mmHg (169 ± 4 * x 182 ± 4 mmHg Sham) there were statistically significant difference. Although the value of systolic arterial pressure (SAP) (196 ± 5 x 207 ± 4 mmHg) showed no differences. There was a decreased in resting HR with a statistically significant difference in the laser group compared to Sham (312 ± 14 vs. 361 ± 13 bpm sham). The spectral reviews in the field of time and frequency showed that the Laser group decreased sympathetic activity on the heart and blood vessels while compared to the Sham group. The heart rate variation was analyzed using the DP-PI ( standard deviation of the pulse interval) VAR-PI components (pulse interval variability) and it demonstrated that LLLT was effective in diminishing variation in heart rate (HR) and sympathetic activity in heart, inducing a substantial fall in blood pressure. Lasertherapy presented a rise in spectral low-frequency component in the pulse interval (LF - IP action of the sympathetic at heart), though the sham group showed up exaggeratedly decreasing (6.77 ± 4:35 and 2:31 ± 0:16 ms ² Sham) as a function of saturation variation. Thus, there was a significant reduction in sympathetic activity after LLLT using. A high-frequency band on interval pulse HF-IP (parasympathetic activity) showed no statistically significant differences between the groups and Laser Sham group. The baroreceptor sensitivity, assessed by the alpha index, signalized a significant increase in the Laser (1:07 ± 0:23 vs. 0:45 ± 0:20 ms / mmHg Sham) group, presenting an improvement in the receptors sensitivity. The baroreflex results were associated with other relevant data, the VAR - SAP (49.55 ± 15.94 * vs 70.51 ± 13:55 mmHg² Sham) and SD -SAP (6.94 ± 1.21 * vs 8.68 ± 1.11 mmHg Sham) that proved to be diminished in the laser group, indicating baroreflex improvement sensitivity concomitantly to the positive SAP variation reduction of. There were no significant differences in baseline SAP (196 ± 5 vs. 207 ± 4 mmHg Sham) between the two groups. The results in the oxidative stress and autonomic analysis demonstrated an association between increased NO production (nitrite 0:36 ± 0:03 vs 0:26 ± 0:03 nm / mg Sham) and decreased in the vascular sympathetic (LF - SAP 7.28 ± 1.63 * vs 9.86 ± 0.47 Sham), both leading to a profound vasodilatation then a significant fall in of blood pressure. Lasertherapy shown to alter the plasma parameters such as oxidative nitrite, revealing an NO increased metabolism, as described above and, moreover, accounted for a significant reduction in carbonyl plasma concentration (vs 3.93 ± 0.24, 4.75 ± 0:26 * nm / mg Sham). Our experimental study indicate that LLLT was able to reduce the oxidative stress parameters through diminishing the damage to the proteins. The enzymatic defense was analyzed by the enzyme SOD concentration in blood plasma, denoted that no significant differences (4:42 ± 0:10 4:25 ± 0:06 vs usod / mg) between groups. Thus, low level laser therapy has shown to improve cardiovascular autonomic activity as well as oxidative parameters which resulted in steadily staggeringly reduce the blood pressure of hypertensive animals.
Em razão do aumento populacional e a senescência, o número de indivíduos com Hipertensão Arterial Sistêmica (HAS) cresceu de 600 milhões em 1980 para 1,2 bilhões (OMS 2011). Lim (2012) atribuiu que a pressão arterial (PA) elevada fosse a causa mortis de 9,5 milhões de indivíduos ao redor do mundo. Atualmente, a HAS tornou-se um grave problema de saúde pública. A hipertensão é um importante fator de risco para insuficiência cardíaca congestiva, doenças cerebrovasculares, infarto agudo do miocárdio, nefropatia, insuficiência vascular periférica e retinopatia hipertensiva. Considerando publicações científicas que demonstram que o componente da inflamação e do estresse oxidativo estão intimamente relacionados à gênese da hipertensão arterial sistêmica (HAS), e que o laser com potência baixa tem efeito positivo no estresse oxidativo e apresenta ação antiinflamatória eficaz, desta forma buscamos estudar a resposta da Laserterapia na HAS. Inúmeros estudos vêm sugerindo, ao longo de décadas, que a fotobiomulação pelo laser empregado uma potência baixa, atua durante as fases inflamatórias e proliferativas da reparação tissular, modulando síntese de mediadores inflamatórios e espécies reativas de oxigênio (ROS). O objetivo deste estudo foi analisar os efeitos da aplicação do laser de baixa intensidade em ratos espontaneamente hipertensos SHR (Spontaneously Hypertensive Rats) em longo prazo na modulação autonômica cardiovascular e no estresse oxidativo sangúineo. Estudo prospectivo, randomizado e controlado com 16 ratos SHR, divididos aleatoriamente em 2 grupos: Sham (n=8) e Laser (n=8).O experimento foi dividido em três fases: Fase I – Irradiação dos animais: constituiu-se na irradiação com laser nos animais SHR, onde o grupo Laser recebeu três aplicações semanais de LBI durante sete semanas; já no grupo Sham foram realizados três simulações de aplicação semanais de Laser de Baixa Intensidade (LBI) durante 7 semanas, totalizando 21 aplicações de LBI. Os animais foram irradiados pontualmente, na região dorsal da cauda, utilizando um Laser Diodo (MMOptics, São Carlos, SP, Brasil) com comprimento de onda de λ = 780 ± 2 (nm); potência de 40 mW, área do feixe de 0,04 cm2, densidade de energia de 30 J/cm2, densidade de potência de 1W/cm2, tempo total de irradiação de 90 s de exposição. Fase II – Avaliação hemodinâmica e autonômica cardiovascular: constituiu-se nos procedimento de canulação, registro de dados e coleta de material, teve inicio após sete semanas de irradiação. Os animais canulados foram avalidados de forma hemodinâmica, bem como analisada a modulação autonômica cardiovascular. Fase III – Análises do estresse oxidativo, foram analisadas: a) danos à proteína; b) danos à membrana celular; c) atividade enzimática; d) concentração de nitrito. Os dados da fase II e III foram coletados e analisados estatisticamente através dos testes Anova One Way, seguido de Post Hoc de Student Newman-Keulls, considerando-se o nível de significância p < 0,05, equivalendo a um erro α de 0.05. Os resultados hemodinâmicos do grupo tratado com LLLT denotaram um decréscimo significativo da PA quando comparado com o grupo Sham. A pressão arterial diastólica (PAD) do grupo Laser revelou uma redução de -14 mmHg (143± 4*vs157±3 mmHg Sham) e a pressão arterial média (PAM) -13mmHg (169±4*vs182±4 mmHg Sham), a frequência cardíaca (FC) em repouso (312±14*vs361±13 bpm Sham) revelando uma diferença estatisticamente significante, porém o valor da pressão arterial sistólica(PAS) não mostrou (196±5 x 207±4 mmHg) alterações entre os grupos. As avaliações espectrais no domínio do tempo e da frequencia demostraram que o grupo Laser reduziu a atividade simpática sobre o coração e vasos sanguíneos quando comparados ao grupo Sham. A variação frequência cardíaca foi analisada através dos componentes VAR-IP (variabilidade do intervalo de pulso) e o DP-IP (desvio do intervalo de pulso) que evidenciaram que o LBI foi eficaz no decréscimo variação da FC e da atividade simpática no coração, induzindo assim a queda das pressões arteriais. A laserterapia mostrou um incremento no componente espectral baixa frequência no intervalo de pulso (BF-IP ação do simpático no coração), porém o grupo Sham apresentou-se exacerbadamente diminuído (6.77 ± 4.35 e 2.31±0.16 ms² Sham) em função da saturação da variação desse componente que foi reduzido. Desta forma, houve um importante decréscimo da atividade simpática com o uso do LBI, significando uma importante diminuição dos níveis pressóricos. A banda de alta frequência (AF-IP atividade parassimpática cardíaca) não mostrou diferenças estatísticas significantes entre os grupos Laser e grupo Sham. A sensibilidade dos barorreceptores, avaliada pelo índice alfa, demonstrou um significativo incremento da resposta no grupo Laser (1.07 ± 0.23 vs 0.45 ± 0.20 ms/mmHg Sham), revelando uma melhora na sensibilidade destes receptores. Os resultados dos barorreflexos encontravam-se associados a outro dado relevante, o componente VAR-PAS (49.55 ± 15.94* vs 70.51 ± 13.55 mmHg² Sham) e DP-PAS (6.94 ± 1.21* vs 8.68 ± 1.11 mmHg Sham) que mostrou-se diminuído no grupo Laser, indicando que a melhora da sensibilidade barorreflexa ocorreu, concomitantemente, à redução positiva da variação da PAS. Não houve diferenças estatísticas significantes na PAS basal (196±5 vs 207 ± 4 mmHg Sham) entre os dois grupos. Já os resultados encontrados na análise do estresse oxidativo e autonômica demonstraram uma associação entre o incremento da produção do óxido nitrico (NO) (nitrito 0.36 ± 0.03 vs 0.26 ± 0.03 nm/mg Sham) e redução do simpático vascular (BF-PAS 7.28 ± 1.63* vs 9.86 ± 0.47 Sham), ambos levando a uma vasodilatação com consequente queda dos níveis pressóricos arteriais. A laserterapia mostrou alterar parâmetros oxidativos como as espécies reativas de nitrogênio (RNS reactive nitrogen species), o nitrito plasmático, revelando um aumento do metabolismo do NO, como já descrito anteriormente e denotou uma diminuição significativa da concentração de carbonilas plasmáticas (3.93 ± 0.24 * vs 4.75 ± 0.26 nm/mg Sham). A defesa enzimática foi analisada através da concentração da enzima SOD no plasma sanguíneo, que não apontou diferenças significativas (4.42 ± 0.10 vs 4.25 ± 0.06 usod/mg) entre os grupos. Evidenciamos que o LBI foi capaz de reduzir este parâmetro oxidativo, reduzindo os danos às proteínas decorrente do estresse. Desta forma, concluímos que a laserterapia demonstrou resposta positiva ao melhorar a atividade autonômica cardiovascular e parâmetros oxidativos que resultaram na redução dos níveis pressóricos dos animais hipertensos.

The autonomic nervous system consists of three divisions: the sympathetic (thoracolumbar), parasympathetic (craniosacral), and enteric nervous systems. The sympathetic and parasympathetic autonomic outflows involve a two-neuron pathway with a synapse in an autonomic ganglion. Preganglionic sympathetic neurons are organized into various functional units that control specific targets and include skin vasomotor, muscle vasomotor, visceromotor, pilomotor, and sudomotor units. Microneurographic techniques allow recording of postganglionic sympathetic nerve activity in humans. Skin sympathetic activity is a mixture of sudomotor and vasoconstrictor impulses and is regulated mainly by environmental temperature and emotional influences. Muscle sympathetic activity is composed of vasoconstrictor impulses that are strongly modulated by arterial baroreceptors. Heart rate is controlled by vagal parasympathetic and thoracic sympathetic inputs. Vagal influence on the heart rate is strongly modulated by respiration; it is more marked during expiration and is absent during inspiration. This is the basis for the so-called respiratory sinus arrhythmia, which is an important index of vagal innervation of the heart. Power spectral analysis of heart rate fluctuations allows noninvasive assessment of beat-to-beat modulation of neuronal activity affecting the heart. Arterial baroreflex, cardiopulmonary reflexes, venoarteriolar reflex, and ergoreflexes control sympathetic and parasympathetic influences on cardiovascular effectors. The main regulatory mechanism that prevents orthostatic hypotension is reflex arterial vasoconstriction in the splanchnic, renal, and muscular beds triggered by a decrease in transmural pressure at the level of carotid sinus baroreceptors.

Drugs able to modulate the autonomic nervous system have improved the outcome of many cardiovascular and non-cardiovascular conditions. In particular, heart failure, post-myocardial infarction, and hypertension are the cardiovascular clinical syndromes in which autonomic nervous system inhibition or stimulation has modified patient outcomes. While in heart failure and post-myocardial infarctions beta blockers have become a cornerstone therapy by improvement of morbidity and mortality, their use in hypertension has been progressively limited. The same is true for other drugs modulating the autonomic nervous system such as alpha blockers, used only in patients with difficult to control hypertension and not in heart failure patients, in whom this class of drugs exacerbates heart failure in clinical trials. This chapter aims to provide an appraisal of drugs modulating the autonomic nervous system with descriptions of their mechanism(s) of action, pharmacokinetics, adverse effects, and drug interactions.

Type 2 Diabetes Mellitus is associated with both macro- and microvascular complications. One among the latter, is cardiovascular autonomic neuropathy (CAN). CAN is attributed to cardiac arrhythmias and sudden death. Underlying pathogenesis of cardiac autonomic neuropathy is chronic hyperglycemia induced oxidative stress causing neuronal necrosis, apoptosis and death, leading to the sympathetic and parasympathetic nerve dysfunction. The balance between sympathetic and parasympathetic nervous system is reflected by heart rate variability (HRV). HRV describes “the variations of both instantaneous heart rate and R-R intervals which in turn reflects the cardiac autonomic nervous control”. HRV measured at rest is a marker of autonomic nerve function status. Thus, HRV test is recommended to diagnose diabetic CAN. Time domain parameters predominantly reflect overall autonomic activity and parasympathetic nervous system (PNS) modulations. Frequency domain parameters either reflect, sympathetic nervous system (SNS) activity, PNS activity, or the balance between the two activities. Nonlinear HRV indices marks PNS influences, SNS influences and sympatho-vagal balance. Almost all these HRV parameters are remarkably reduced in T2DM due to cardiac autonomic dysfunction. HRV is an important simple and noninvasive diagnostic tool to detect CAN.

Advancing technology and global commerce have created a 24-hour society where the natural constraints on human activity of geography and distance are dissolving. The competitive challenge of this world offers excitement and opportunity, but also chronic stress, which is frequently experienced by individuals as anxiety and time urgency. Sleep deprivation is commonplace and often self-imposed. The cascade of physiological disruption so engendered has unintended health consequences including cardiovascular disease and obesity. In the latter, there is growing evidence that, together with reduced exercise, short sleep may help drive weight gain by disrupting the bi-directional communication among the body's autonomic, endocrine and immune systems and the brain. The homeostasis of the pro-inflammatory cytokines, and the appetite-modulating peptides, ghrelin and leptin, in each instance is disturbed by sleep debt. This biology is reviewed, together with a discussion of its implications within the broader social context.